Tags

Type your tag names separated by a space and hit enter

Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy.

Abstract

Purpose

To describe a case of ophthalmic artery occlusion and complete ophthalmoplegia after intralesional injection of a sclerosing agent into a subcutaneous hemangioma on the forehead.

Case Report

A 16-year-old girl underwent direct injection of 3 mL of sodium tetradecyl sulfate (Fibrovein) emulsion 1% (10 mg/mL) with a 23-gauge needle into a subcutaneous hemangioma on the forehead. Immediately after the injection, she developed sudden loss of vision and lid swelling of the left eye. Her visual acuity in the left eye became no light perception. Her left eye also developed a dilated pupil, ptosis, and complete external ophthalmoplegia. Funduscopy of the left eye revealed signs of central retinal artery occlusion. Magnetic resonance imaging of the orbit showed thickening of the medial and lateral rectus muscles of the left eye. Magnetic resonance venography of the brain was normal with no evidence of cavernous venous thrombosis. After 3 months, her ptosis and ophthalmoplegia resolved but her visual acuity remained no light perception.

Conclusion

Persistent total visual loss should be kept in mind as a disastrous complication of sclerosing therapy in a patient with facial hemangioma.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

    ,

    Emam Khomeini Eye Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

    ,

    Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

    ,

    Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

    Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Florida, USA.

    Source

    Pub Type(s)

    Case Reports

    Language

    eng

    PubMed ID

    30090194

    Citation

    Dehghani, Alireza, et al. "Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy." Journal of Ophthalmic & Vision Research, vol. 13, no. 3, 2018, pp. 351-354.
    Dehghani A, Rezaei L, Ghanbari H, et al. Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy. J Ophthalmic Vis Res. 2018;13(3):351-354.
    Dehghani, A., Rezaei, L., Ghanbari, H., Nasrollahi, K., & Tavakoli, M. (2018). Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy. Journal of Ophthalmic & Vision Research, 13(3), pp. 351-354. doi:10.4103/jovr.jovr_29_16.
    Dehghani A, et al. Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy. J Ophthalmic Vis Res. 2018;13(3):351-354. PubMed PMID: 30090194.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy. AU - Dehghani,Alireza, AU - Rezaei,Leila, AU - Ghanbari,Heshmatollah, AU - Nasrollahi,Kobra, AU - Tavakoli,Mehdi, PY - 2018/8/10/entrez PY - 2018/8/10/pubmed PY - 2018/8/10/medline KW - Central Retinal Artery Occlusion KW - Hemangioma KW - Ophthalmoplegia KW - Sclerosing Agent KW - Sclerotherapy SP - 351 EP - 354 JF - Journal of ophthalmic & vision research JO - J Ophthalmic Vis Res VL - 13 IS - 3 N2 - Purpose: To describe a case of ophthalmic artery occlusion and complete ophthalmoplegia after intralesional injection of a sclerosing agent into a subcutaneous hemangioma on the forehead. Case Report: A 16-year-old girl underwent direct injection of 3 mL of sodium tetradecyl sulfate (Fibrovein) emulsion 1% (10 mg/mL) with a 23-gauge needle into a subcutaneous hemangioma on the forehead. Immediately after the injection, she developed sudden loss of vision and lid swelling of the left eye. Her visual acuity in the left eye became no light perception. Her left eye also developed a dilated pupil, ptosis, and complete external ophthalmoplegia. Funduscopy of the left eye revealed signs of central retinal artery occlusion. Magnetic resonance imaging of the orbit showed thickening of the medial and lateral rectus muscles of the left eye. Magnetic resonance venography of the brain was normal with no evidence of cavernous venous thrombosis. After 3 months, her ptosis and ophthalmoplegia resolved but her visual acuity remained no light perception. Conclusion: Persistent total visual loss should be kept in mind as a disastrous complication of sclerosing therapy in a patient with facial hemangioma. SN - 2008-2010 UR - https://www.unboundmedicine.com/medline/citation/30090194/Ophthalmic_Artery_Occlusion_Following_Facial_Sclerosing_Therapy_ L2 - http://www.jovr.org/article.asp?issn=2008-322X;year=2018;volume=13;issue=3;spage=351;epage=354;aulast=Dehghani DB - PRIME DP - Unbound Medicine ER -